4//SEC Filing
Karkus Ted William 4
Accession 0001493152-23-003428
CIK 0000868278other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:33 PM ET
Size
9.8 KB
Accession
0001493152-23-003428
Insider Transaction Report
Form 4
Karkus Ted William
10% Owner
Transactions
- Exercise/Conversion
Option (right to buy)
2023-02-01−500,000→ 0 totalExercise: $0.60Exp: 2023-02-22→ Common Stock (500,000 underlying) - Tax Payment
Common Stock, par value $0.005
2023-02-01$8.18/sh−268,337$2,194,997→ 3,583,750 total - Exercise/Conversion
Common Stock, par value $0.005
2023-02-01$0.60/sh+500,000$300,000→ 3,852,087 total
Holdings
- 100,000(indirect: By Son)
Common Stock, par value $0.005
Footnotes (2)
- [F1]On February 1, 2023, the Reporting Person acquired net 231,663 shares of common stock upon the exercise of stock options to purchase 500,000 shares of common stock, less 268,337 shares of common stock withheld to cover the exercise price and applicable taxes.
- [F2]The option vested in 35 equal monthly installments of 63,888 shares on the 1st day of each month beginning on March 1, 2018 (the "Initial Vesting Date"), and one monthly installment of 63,920 shares on the 1st day of the 36th month following the Initial Vesting Date, as described in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of February 19, 2018.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeother
Related Parties
1- filerCIK 0001457896
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 4:33 PM ET
- Size
- 9.8 KB